Comparison of two estradiol transdermal systems (Oesclim® 50 and Estraderm TTS® 50). I. Tolerability, adhesion and efficacy
- 30 November 1996
- Vol. 25 (3) , 161-173
- https://doi.org/10.1016/s0378-5122(96)01068-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Efficacy and tolerability of Menorest® 50 compared with estraderm® TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group studyMaturitas, 1995
- A pilot study of the comparative bioavailability of estradiol from two different estradiol transdermal systems: Oesclim® 50 and Systen® 50Current Therapeutic Research, 1995
- CLINICAL REVIEW 27 Effects of Hormonal Replacement on Lipids and Lipoproteins in Postmenopausal WomenJournal of Clinical Endocrinology & Metabolism, 1991
- Postmenopausal Estrogen Therapy and Cardiovascular DiseaseNew England Journal of Medicine, 1991
- Comparative metabolic study of percutaneous versus oral micronized 17β-oestradiol in replacement therapyMaturitas, 1989
- A randomized comparison of nonoral estradiol delivery in postmenopausal womenAmerican Journal of Obstetrics and Gynecology, 1988
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986
- Biological Effects of Estradiol-17β in Postmenopausal Women: Oral Versus percutaneous AdministrationJournal of Clinical Endocrinology & Metabolism, 1986
- Treatment of Hot Flashes with Transdermal Estradiol Administration*Journal of Clinical Endocrinology & Metabolism, 1985
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976